← Back to Clinical Trials
Recruiting NCT07622277

NCT07622277 Comparative 3-dimensional Superimposition Analysis of Dentition in Horizontal and Vertical Grower During the Retention Phase -A Prospective Clinical Trial''

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07622277
Status Recruiting
Phase
Sponsor Postgraduate Institute of Dental Sciences Rohtak
Condition Retention
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2025-02-04
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
3 planes of space

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2025-02-04 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the relationship between facial type and relapse of dentition post-orthodontically during the retention phase. According to the retention theorem "teeth which have been moved through orthodontic treatment tend to naturally return to their original position. It is hypothesized that significant differences will exist in tooth movement patterns between horizontal and vertical growers, with horizontal growers exhibiting more pronounced tooth movement in the vertical plane particularly in the overbite as compared to the vertical growers . Furthermore, it is expected that facial type will influence the stability of orthodontic treatment outcomes, with long-faced individuals showing more relapse of mandibular incisor alignment and crowding. By exploring this relationship, this study aims to provide valuable insights into the factors influencing orthodontic treatment outcomes and stability. With long-faced individuals exhibiting more mandibular backward rotation and short-faced individuals showing forward rotation, which increases the risk of deep bite . Additionally, understanding these factors is crucial for orthodontists to predict and prevent potential relapse, ensuring optimal treatment results and long-term stability. Hence, the present trial will be undertaken to assess the changes and compare If there is any difference in tooth movement in 3-Dimensional superimposition in the dentition in horizontal and vertical growers post orthodontically over a period of retention phase.

Eligibility Criteria

Inclusion Criteria: * Fixed orthodontic cases with FMA of 26 0 or more for hyperdivergent cases and FMA Of 24 o or less for hypodivergent cases. * Optimal functional occlusion at end of treatment (PAR score \>70%). * Littles irregularity index (Pre-treatment \<6mm in both upper and lower arch). * Nonsurgical and non-orthopedic patients and non syndromic patients. * Optimal periodontal condition and Good oral hygiene (probing depth \<3mm, gingival index score \<1 * Good compliance regarding retainer wear Exclusion Criteria: * Subjects with incomplete orthodontic treatment. * TMJ disorder patients. * Any systemic disease affecting bone and general growth. * Patients with incomplete records * Patient who fail to follow up or undergo complete treatment. * Patient with learning difficulties * Patients having antibiotic therapy within previous 3 months and used anti inflammatory drugs in the month before the study

Contact & Investigator

Central Contact

Dr Manisha kamal kukreja, MDS

✉ mk3pgids@gmail.com

📞 9215650617

Principal Investigator

Dr manisha Kamal kukreja, MDS

STUDY DIRECTOR

PGIDS Rohtak

Frequently Asked Questions

Who can join the NCT07622277 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Retention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07622277 currently recruiting?

Yes, NCT07622277 is actively recruiting participants. Contact the research team at mk3pgids@gmail.com for enrollment information.

Where is the NCT07622277 trial being conducted?

This trial is being conducted at Rohtak, India.

Who is sponsoring the NCT07622277 clinical trial?

NCT07622277 is sponsored by Postgraduate Institute of Dental Sciences Rohtak. The principal investigator is Dr manisha Kamal kukreja, MDS at PGIDS Rohtak. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology